Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, Hohmann E, Chu HY, Luetkemeyer A, Kline S, Lopez de Castilla D, Finberg RW, Dierberg K, Tapson V, Hsieh L, Patterson TF, Paredes R, Sweeney DA, Short WR, Touloumi G, Lye DC, Ohmagari N, Oh M, Ruiz-Palacios GM, Benfield T, Fätkenheuer G, Kortepeter MG, Atmar RL, Creech CB, et al. Remdesivir for the Treatment of Covid-19 — Final Report. N Engl J Med. 2020;383:1813–26.

Article  CAS  PubMed  Google Scholar 

Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature. 2000;405:458–62.

Article  CAS  PubMed  Google Scholar 

Bricher Choque PN, Vieira RP, Ulloa L, Grabulosa C, Irigoyen MC, De Angelis K, Ligeiro De Oliveira AP, Tracey KJ, Pavlov VA, Consolim-Colombo FM. The Cholinergic Drug Pyridostigmine Alleviates Inflammation During LPS-Induced Acute Respiratory Distress Syndrome. Frontiers in Pharmacology 2021.

Cifuentes-Faura J. COVID-19 mortality rate and its incidence in Latin America: Dependence on demographic and economic variables. International Journal of Environmental Research and Public Health 2021;18.

Cox MA, Duncan GS, Lin GHY, Steinberg BE, Yu LX, Brenner D, Buckler LN, Elia AJ, Wakeham AC, Nieman B, Dominguez-Brauer C, Elford AR, Gill KT, Kubli SP, Haight J, Berger T, Ohashi PS, Tracey KJ, Olofsson PS, Mak TW. Choline acetyltransferase–expressing T cells are required to control chronic viral infection. Sci (1979). 2019;363:639–44.

CAS  Google Scholar 

de Souza FSH, Hojo-Souza NS, Batista BD, de O, da Silva CM, Guidoni DL. On the analysis of mortality risk factors for hospitalized COVID-19 patients: A data-driven study using the major Brazilian database. PLoS ONE. 2021;16:e0248580.

Article  PubMed  PubMed Central  Google Scholar 

Fragoso-Saavedra S, Iruegas-Nunez DA, Quintero-Villegas A, García-González HB, Nuñez I, Carbajal-Morelos SL, Audelo-Cruz BM, Arias-Martínez S, Caro-Vega Y, Calva JJ, Luqueño-Martínez V, González-Duarte A, Crabtree-Ramírez B, Crispín JC, Sierra-Madero J, Belaunzarán-Zamudio PF, Valdés-Ferrer SI. A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol. BMC Infect Dis. 2020;20:765.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gilhus NE, Verschuuren JJ. Myasthenia gravis: Subgroup classification and therapeutic strategies. Lancet Neurol. 2015;14:1023–36.

Article  CAS  PubMed  Google Scholar 

Guimarães PO, Quirk D, Furtado RH, Maia LN, Saraiva JF, Antunes MO, Kalil Filho R, Junior VM, Soeiro AM, Tognon AP, Veiga VC, Martins PA, Moia DDF, Sampaio BS, Assis SRL, Soares RVP, Piano LPA, Castilho K, Momesso RGRAP, Monfardini F, Guimarães HP, Ponce de Leon D, Dulcine M, Pinheiro MRT, Gunay LM, Deuring JJ, Rizzo LV, Koncz T, Berwanger O. Tofacitinib in Patients Hospitalized with Covid-19 Pneumonia. New England Journal of Medicine 2021;385:406–415.

Horby P, Lim WS, Emberson J, Mafham M, Bell J, Linsell L, Staplin N, Birghtling C, Ustianowski A, Elmahi E, Prudon B, Green C, Felton T, Baillie K, Haynes R, Landray M. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021a;384:693–704.

Article  CAS  PubMed  Google Scholar 

Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, Phil D, Staplin N, Brightling C, Med F, Sci A, Ustianowski E, Elmahi M, Phil B, Prudon FRCP, Green C, Felton T-O, Chadwick D, Rege K, Path FRC, Fegan C-T, Chappell LC, Faust SN, Jaki T, Jeffery K, Mont-Gomery A, Rowan K, Juszczak E-M, Kenneth Baillie J, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021b;384:693–704.

Article  CAS  PubMed  Google Scholar 

Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395:497–506.

Article  CAS  Google Scholar 

Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, Marconi VC, Ruiz-Palacios GM, Hsieh L, Kline S, Tapson V, Iovine NM, Jain MK, Sweeney DA, el Sahly HM, Branche AR, Regalado Pineda J, Lye DC, Sandkovsky U, Luetkemeyer AF, Cohen SH, Finberg RW, Jackson PEH, Taiwo B, Paules CI, Arguinchona H, Erdmann N, Ahuja N, Frank M, et al. Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19. N Engl J Med. 2021;384:795–807.

Article  CAS  PubMed  Google Scholar 

Keeler JR, Hurst CG, Dunn MA. Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions. JAMA: The Journal of the American Medical Association. 1991;266:693–5.

Article  CAS  PubMed  Google Scholar 

Lehner KR, Silverman HA, Addorisio ME, Roy A, Al-Onaizi MA, Levine Y, Olofsson PS, Chavan SS, Gros R, Nathanson NM, Al-Abed Y, Metz CN, Prado VF, Prado MAM, Tracey KJ, Pavlov VA. Forebrain cholinergic signaling regulates innate immune responses and inflammation. Front Immunol. 2019;10:1–11.

Article  Google Scholar 

Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ. COVID-19: consider cytokine storm syndromes and immunosuppression. The Lancet. 2020;395:1033–4.

Article  CAS  Google Scholar 

Núñez I, Priego-Ranero ÁA, García-González HB, Jiménez-Franco B, Bonilla-Hernández R, Domínguez-Cherit G, Merayo-Chalico J, Crispín JC, Barrera-Vargas A, Valdés-Ferrer SI. Common hematological values predict unfavorable outcomes in hospitalized COVID-19 patients. Clin Immunol. 2021;225:108682.

Article  PubMed  PubMed Central  Google Scholar 

Núñez I, Valdés-Ferrer SI, Soto-Mota A. Hospitalization as an outcome in ambulatory COVID-19 trials—not applicable in every setting. Clin Microbiol Infect. 2022. doi:https://doi.org/10.1016/j.cmi.2022.05.026.

Article  PubMed  PubMed Central  Google Scholar 

Olivas-Martínez A, Cárdenas-Fragoso JL, Jiménez JV, Lozano-Cruz OA, Ortiz-Brizuela E, Tovar-Méndez VH, Medrano-Borromeo C, Martínez-Valenzuela A, Román-Montes CM, Martínez-Guerra B, González-Lara MF, Hernandez-Gilsoul T, Herrero AG, Tamez-Flores KM, Ochoa-Hein E, Ponce-De-León A, Galindo-Fraga A, Kershenobich-Stalnikowitz D, Sifuentes-Osornio J. In-hospital mortality from severe COVID-19 in a tertiary care center in Mexico City; causes of death, risk factors and the impact of hospital saturation. PLoS ONE. 2021;16:1–17.

Article  Google Scholar 

Ouyang SM, Zhu HQ, Xie YN, Zou ZS, Zuo HM, Rao YW, Liu XY, Zhong B, Chen X. Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19. BMC Infect Dis. 2020;20:1–10.

Article  Google Scholar 

Pavlov VA, Tracey KJ. Neural regulation of immunity: Molecular mechanisms and clinical translation. Nat Neurosci. 2017;20:156–66.

Article  CAS  PubMed  Google Scholar 

Pinheiro NM, Banzato R, Tibério I, Prado MAM, Prado VF, Hamouda AK, Prado CM. Acute lung injury in cholinergic-deficient mice supports anti-inflammatory role of α7 nicotinic acetylcholine receptor. International Journal of Molecular Sciences 2021;22.

RECOVERY Collaborative Group. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): preliminary results of a randomised, controlled, open-label, platform trial. Lancet. 2021;397:1637–45.

Article  Google Scholar 

Robinson-Papp J, Nmashie A, Pedowitz E, George MC, Sharma S, Murray J, Benn EKT, Lawrence SA, Machac J, Heiba S, Kim-Schulze S, Navis A, Roland BC, Morgello S. The effect of pyridostigmine on small intestinal bacterial overgrowth (SIBO) and plasma inflammatory biomarkers in HIV-associated autonomic neuropathies. J Neurovirol. 2019;25:551–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rosas-Ballina M, Olofsson PS, Ochani M, Valdés-Ferrer SI, Levine YA, Reardon C, Tusche MW, Pavlov VA, Andersson U, Chavan S, Mak TW, Tracey KJ. Acetylcholine-Synthesizing T Cells Relay Neural Signals in a Vagus Nerve Circuit. Science. 2011;334:98–101.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossman H, Meir T, Somer J, Shilo S, Segal E, Shalit U, Gor M, Gutman R, Arie A, Ben. Hospital load and increased COVID-19 reñated mortality in Israel. Nat Commun. 2021;12:1–7.

Article  Google Scholar 

Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020;46:846–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Su X, Matthay MA, Malik AB. Requisite Role of the Cholinergic α7 Nicotinic Acetylcholine Receptor Pathway in Suppressing Gram-Negative Sepsis-Induced Acute Lung Inflammatory Injury. J Immunol. 2010;184:401–10.

Article  CAS  PubMed  Google Scholar 

Taboada B, Zárate S, Iša P, Boukadida C, Armando Vazquez-Perez J, Esteban Muñoz-Medina J, Ramírez-González E, Comas-García A, Grajales-Muñiz C, Rincón-Rubio A, Matías-Florentino M, Sanchez-Flores A, Mendieta-Condado E, Verleyen J, Barrera-Badillo G, Hernández-Rivas L, Mejía-Nepomuceno F, Arturo Martínez-Orozco J, Becerril-Vargas E, López S, López-Martínez I, Ávila-Ríos S, Arias CF, Ferreira HL, Luiz J, Módena P. Marciel De Souza W. Genetic Analysis of SARS-CoV-2 Variants in Mexico during the First Year of the COVID-19 Pandemic. 2021;doi:https://doi.org/10.3390/v13112161.

Valdés-Ferrer SI, Crispín JC, Belaunzarán-Zamudio PF, Cantú-Brito CG, Sierra-Madero JG, Alcocer-Varela J. Acetylcholine-Esterase Inhibitor Pyridostigmine Decreases T Cell Overactivation in Patients Infected by HIV. AIDS Res Hum Retroviruses. 2009;25:749–55.

Article  PubMed  Google Scholar 

Valdés-Ferrer SI, Crispín JC, Belaunzarán-Zamudio PF, Rodríguez-Osorio CA, Cacho-Díaz B, Alcocer-Varela J, Cantú-Brito C, Sierra-Madero J. Add-on Pyridostigmine Enhances CD4 + T-Cell Recovery in HIV-1-Infected Immunological Non-Responders: A Proof-of-Concept Study. Frontiers in Immunology 2017;8.

Wang J, Yang X, Li Y, Huang J, an, Jiang J, Su N. Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Virol J. 2021;18:1–12.

Article  Google Scholar 

Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, Liu S, Zhao P, Liu H, Zhu L, Tai Y, Bai C, Gao T, Song J, Xia P, Dong J, Zhao J, Wang FS. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. The Lancet Respiratory Medicine. 2020;8:420–2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. A Novel Coronavirus from Patients with Pneumonia in China, 2019. N Engl J Med. 2020;382:727–33.

Article  CAS  PubMed  PubMed Central  Google Scholar